ClinicalTrials.gg
CompletedNCT07808281Updated Sep 8, 2026

Association Between Preoperative Mediterranean Diet Adherence and Postoperative Bowel Motility

An observational study in Post Abdominal Surgery, Gastrointestinal Motility Disorder and Postoperative Ileus, sponsored by Bahçeşehir University. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Bahçeşehir University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Postoperative bowel motility is an important indicator of recovery after abdominal surgery and may be influenced by preoperative nutritional status. Adherence to the Mediterranean diet has been associated with favorable gastrointestinal function because of its high content of dietary fiber, unsaturated fatty acids, polyphenols, and other bioactive compounds. This prospective observational cohort study aims to investigate the association between preoperative adherence to the Mediterranean diet and postoperative bowel motility in adults undergoing elective abdominal surgery. A total of 110 participants will be assessed for Mediterranean diet adherence using the Mediterranean Diet Adherence Screener (MEDAS). Nutritional status, dietary intake, and perioperative characteristics will be recorded. Postoperative bowel motility outcomes, including time to first bowel sound, first flatus, first defecation, oral intake, and hospital discharge, will be prospectively monitored. The findings are expected to improve understanding of the relationship between preoperative dietary patterns and postoperative gastrointestinal recovery.

Read the detailed description

Postoperative bowel motility is one of the most important indicators of recovery following abdominal surgery. Delayed gastrointestinal motility is associated with postoperative ileus, prolonged hospital stay, delayed oral feeding, and increased healthcare costs. Several factors, including surgical stress, anesthesia, inflammation, and preoperative nutritional status, may influence the recovery of bowel function after surgery.

The Mediterranean diet is characterized by a high intake of vegetables, fruits, legumes, whole grains, olive oil, nuts, and fish, and a low intake of red and processed meat. This dietary pattern provides dietary fiber, unsaturated fatty acids, polyphenols, antioxidants, and other bioactive compounds that may improve gut microbiota composition, reduce inflammation, and support normal gastrointestinal function. Previous studies have demonstrated beneficial effects of the Mediterranean diet on gastrointestinal health; however, evidence regarding its association with postoperative bowel motility remains limited.

This prospective observational cohort study aims to investigate the association between preoperative adherence to the Mediterranean diet and postoperative bowel motility in adults undergoing elective laparoscopic cholecystectomy. A total of 110 participants will be enrolled after ethics committee approval. Preoperative nutritional status, dietary intake, and adherence to the Mediterranean diet will be assessed using the Mediterranean Diet Adherence Screener (MEDAS), food frequency questionnaires, and three-day dietary records. Demographic, anthropometric, clinical, and perioperative data will also be collected.

Postoperative bowel function will be prospectively evaluated by recording the time to first bowel sound, first passage of flatus, first defecation, first oral intake, and hospital discharge. Dietary nutrient intake will be analyzed using a nutrition analysis software program. The association between Mediterranean diet adherence and postoperative bowel motility outcomes will be examined using appropriate statistical methods. The findings are expected to improve understanding of the role of preoperative dietary quality in postoperative gastrointestinal recovery and may contribute to optimizing perioperative nutritional management in patients undergoing abdominal surgery.

02

Conditions studied

  • Post Abdominal Surgery
  • Gastrointestinal Motility Disorder
  • Postoperative Ileus

Browse trials for

Keywords

  • Mediterranean diet
  • MEDAS
  • Abdominal surgery
  • Gastrointestinal motility
03

In context

Ileus

167 studies on the registry are indexed under Ileus; 23 are open to participants now.

This study's enrollment of 110 is below the median of 159 across 26 observational studies indexed under Ileus.

Browse Ileus studies →

Lead sponsor

Bahçeşehir University is the lead sponsor of 128 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consisted of adults undergoing elective laparoscopic cholecystectomy at the General Surgery Clinic of İnönü University Faculty of Medicine Hospital. Participants were enrolled prospectively between February and April 2026. Preoperative nutritional status and adherence to the Mediterranean diet were assessed before surgery, and postoperative bowel motility outcomes were prospectively monitored during hospitalization.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older and younger than 70 years.
  • Scheduled to undergo elective laparoscopic cholecystectomy.
  • Able to provide written .
  • Able to complete the preoperative Food Frequency Questionnaire (FFQ) and 3-day dietary record.
  • Able to complete all study assessments and postoperative follow-up.

Exclusion criteria

Exclusion Criteria:

  • Cesarean section (obstetric surgery).
  • Emergency abdominal surgery.
  • Structural bowel obstruction following bowel resection or presence of a temporary ileostomy or colostomy.
  • Active inflammatory bowel disease (Crohn's disease or ulcerative colitis) during the preoperative period.
  • Impaired consciousness or inability to provide .
  • Pregnancy.
  • Previous bowel surgery within the last 3 months.
  • Short bowel syndrome or conditions requiring chronic parenteral nutrition.
  • Severe systemic disease.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (actual)
Patient registry
No

Groups and cohorts

  • Adults Undergoing Elective Laparoscopic Cholecystectomy

    Adults undergoing elective laparoscopic cholecystectomy who were enrolled in this prospective observational cohort study. Preoperative nutritional status and adherence to the Mediterranean diet were assessed before surgery. Participants were not assigned to exposure groups; subgroup analyses according to Mediterranean Diet Adherence Screener (MEDAS) scores were performed during statistical analysis. Postoperative bowel motility outcomes were prospectively recorded for all participants.

06

What researchers measure

Primary outcomes

  1. Time to first bowel sound

    Time in hours from completion of surgery, defined as the record time of exit from the operating room, to the first documented bowel sound. Bowel sounds were assessed hourly by surgical residents and recorded on a standardised monitoring form.

    Time frame: From completion of surgery until the first documented bowel sound, assessed during the postoperative hospital stay (up to 48 hours postoperatively).

Secondary outcomes

  1. Time to first flatus

    Time in hours from completion of surgery, defined as the recorded time of exit from the operating room, to the first patient-reported passage of flatus.

    Time frame: From completion of surgery until the first patient-reported passage of flatus, assessed during the postoperative hospital stay (up to 48 hours postoperatively).

  2. Time to first defecation

    Time in hours from completion of surgery, defined as the recorded time of exit from the operating room, to the first patient-reported postoperative defecation.

    Time frame: From completion of surgery until the first patient-reported postoperative defecation, assessed during the postoperative hospital stay (up to 48 hours postoperatively).

  3. Time to first oral fluid intake

    Time in hours from completion of surgery, defined as the recorded time of exit from the operating room, to the first documented postoperative oral fluid intake. The time of oral fluid intake was obtained from hospital records.

    Time frame: From completion of surgery until the first documented oral fluid intake, assessed during the postoperative hospital stay (up to 48 hours postoperatively).

  4. Postoperative Length of Hospital Stay

    Time in hours from completion of surgery, defined as the recorded time of exit from the operating room, until hospital discharge. The time of discharge was obtained from hospital records.

    Time frame: From completion of surgery until hospital discharge, assessed up to 60 days postoperatively.

07

Study locations

2 sites
  • Bahcesehir University
    Istanbul, Turkey (Türkiye)
  • İnönü University Faculty of Medicine Hospital
    Malatya, Turkey (Türkiye)
08

References and documents

Publications

  • Tosti V, Bertozzi B, Fontana L. Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms. J Gerontol A Biol Sci Med Sci. 2018 Mar 2;73(3):318-326. doi: 10.1093/gerona/glx227. PubMed 29244059 ↗
  • Muller SA, Rahbari NN, Schneider F, Warschkow R, Simon T, von Frankenberg M, Bork U, Weitz J, Schmied BM, Buchler MW. Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy. Br J Surg. 2012 Nov;99(11):1530-8. doi: 10.1002/bjs.8885. Epub 2012 Sep 14. PubMed 22987303 ↗
  • Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008 Sep 11;337:a1344. doi: 10.1136/bmj.a1344. PubMed 18786971 ↗
  • Wattchow D, Heitmann P, Smolilo D, Spencer NJ, Parker D, Hibberd T, Brookes SSJ, Dinning PG, Costa M. Postoperative ileus-An ongoing conundrum. Neurogastroenterol Motil. 2021 May;33(5):e14046. doi: 10.1111/nmo.14046. Epub 2020 Nov 30. PubMed 33252179 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2026 to primary completion in Apr 2026, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 2, 2026
First posted
Sep 8, 2026
StartActual
Jan 23, 2026
Primary completionActual
Apr 23, 2026
CompletionActual
May 23, 2026
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07808281
Responsible party
Ilayda Ozturk Altuncevahir (Asst. Prof., Bahçeşehir University) — Principal investigator
First posted
Sep 8, 2026
Start date
Jan 23, 2026
Primary completion
Apr 23, 2026
Completion
May 23, 2026
Last update
Sep 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion